269 related articles for article (PubMed ID: 26248570)
1. Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk.
Zewinger S; Drechsler C; Kleber ME; Dressel A; Riffel J; Triem S; Lehmann M; Kopecky C; Säemann MD; Lepper PM; Silbernagel G; Scharnagl H; Ritsch A; Thorand B; de las Heras Gala T; Wagenpfeil S; Koenig W; Peters A; Laufs U; Wanner C; Fliser D; Speer T; März W
Eur Heart J; 2015 Nov; 36(43):3007-16. PubMed ID: 26248570
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3, Renal Function, and Clinical Outcomes: Results from the LURIC and 4D Studies.
Drechsler C; Delgado G; Wanner C; Blouin K; Pilz S; Tomaschitz A; Kleber ME; Dressel A; Willmes C; Krane V; Krämer BK; März W; Ritz E; van Gilst WH; van der Harst P; de Boer RA
J Am Soc Nephrol; 2015 Sep; 26(9):2213-21. PubMed ID: 25568176
[TBL] [Abstract][Full Text] [Related]
3. Asthmatic patients with high serum amyloid A have proinflammatory HDL: Implications for augmented systemic and airway inflammation.
Yao X; Kaler M; Qu X; Kalidhindi RSR; Sviridov D; Dasseux A; Barr E; Keeran K; Jeffries KR; Yu ZX; Gao M; Gordon S; Barochia AV; Mills J; Shahid S; Weir NA; Kalchiem-Dekel O; Theard P; Playford MP; Stylianou M; Fitzgerald W; Remaley AT; Levine SJ
J Allergy Clin Immunol; 2024 Apr; 153(4):1010-1024.e14. PubMed ID: 38092139
[TBL] [Abstract][Full Text] [Related]
4. Association of serum amyloid A and prognosis in people with diabetes and COVID-19: A retrospective cohort study.
Qu D; Liu J; Zhou L; Yang Y; Wu C; Xu X; Zhu Q; Wang C; Zhao X
J Diabetes Investig; 2024 Jan; 15(1):44-51. PubMed ID: 38031656
[TBL] [Abstract][Full Text] [Related]
5. IL-6 and SAA-Strong Predictors for the Outcome in COVID-19 CKD Patients.
Filev R; Lyubomirova M; Bogov B; Kalinov K; Hristova J; Svinarov D; Rostaing L
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203482
[TBL] [Abstract][Full Text] [Related]
6. Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort.
Schön M; Prystupa K; Mori T; Zaharia OP; Bódis K; Bombrich M; Möser C; Yurchenko I; Kupriyanova Y; Strassburger K; Bobrov P; Nair ATN; Bönhof GJ; Strom A; Delgado GE; Kaya S; Guthoff R; Stefan N; Birkenfeld AL; Hauner H; Seissler J; Pfeiffer A; Blüher M; Bornstein S; Szendroedi J; Meyhöfer S; Trenkamp S; Burkart V; Schrauwen-Hinderling VB; Kleber ME; Niessner A; Herder C; Kuss O; März W; Pearson ER; Roden M; Wagner R;
Lancet Diabetes Endocrinol; 2024 Feb; 12(2):119-131. PubMed ID: 38142707
[TBL] [Abstract][Full Text] [Related]
7. Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes.
Denimal D
Antioxidants (Basel); 2023 Dec; 13(1):. PubMed ID: 38247481
[TBL] [Abstract][Full Text] [Related]
8. Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.
Srivastava RAK
Mol Cell Biochem; 2018 Mar; 440(1-2):167-187. PubMed ID: 28828539
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer.
Zhang XY; Zhang G; Jiang Y; Liu D; Li MZ; Zhong Q; Zeng SQ; Liu WL; Zeng MS
Chin J Cancer; 2015 Aug; 34(8):335-49. PubMed ID: 26264146
[TBL] [Abstract][Full Text] [Related]
10. HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity.
Borja MS; Ng KF; Irwin A; Hong J; Wu X; Isquith D; Zhao XQ; Prazen B; Gildengorin V; Oda MN; Vaisar T
J Lipid Res; 2015 Oct; 56(10):2002-9. PubMed ID: 26254308
[TBL] [Abstract][Full Text] [Related]
11. Dickkopf-3 (DKK3) in Urine Identifies Patients with Short-Term Risk of eGFR Loss.
Zewinger S; Rauen T; Rudnicki M; Federico G; Wagner M; Triem S; Schunk SJ; Petrakis I; Schmit D; Wagenpfeil S; Heine GH; Mayer G; Floege J; Fliser D; Gröne HJ; Speer T
J Am Soc Nephrol; 2018 Nov; 29(11):2722-2733. PubMed ID: 30279273
[TBL] [Abstract][Full Text] [Related]
12. The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study.
Torino C; Gargani L; Sicari R; Letachowicz K; Ekart R; Fliser D; Covic A; Siamopoulos K; Stavroulopoulos A; Massy ZA; Fiaccadori E; Caiazza A; Bachelet T; Slotki I; Martinez-Castelao A; Coudert-Krier MJ; Rossignol P; Gueler F; Hannedouche T; Panichi V; Wiecek A; Pontoriero G; Sarafidis P; Klinger M; Hojs R; Seiler-Mussler S; Lizzi F; Siriopol D; Balafa O; Shavit L; Tripepi R; Mallamaci F; Tripepi G; Picano E; London GM; Zoccali C
Clin J Am Soc Nephrol; 2016 Nov; 11(11):2005-2011. PubMed ID: 27660305
[TBL] [Abstract][Full Text] [Related]
13. Consequences of chronic kidney disease in chronic obstructive pulmonary disease.
Trudzinski FC; Alqudrah M; Omlor A; Zewinger S; Fliser D; Speer T; Seiler F; Biertz F; Koch A; Vogelmeier C; Welte T; Watz H; Waschki B; Fähndrich S; Jörres R; Bals R;
Respir Res; 2019 Jul; 20(1):151. PubMed ID: 31299972
[TBL] [Abstract][Full Text] [Related]
14. Early low-dose erythropoiesis-stimulating agent therapy and progression of moderate chronic kidney disease: a randomized, placebo-controlled trial.
Fliser D; Dellanna F; Koch M; Wiggenhauser A;
Nephrol Dial Transplant; 2017 Feb; 32(2):279-287. PubMed ID: 28186540
[TBL] [Abstract][Full Text] [Related]
15. Oral vancomycin treatment does not alter markers of postprandial inflammation in lean and obese subjects.
Bakker GJ; Schnitzler JG; Bekkering S; de Clercq NC; Koopen AM; Hartstra AV; Meessen ECE; Scheithauer TP; Winkelmeijer M; Dallinga-Thie GM; Cani PD; Kemper EM; Soeters MR; Kroon J; Groen AK; van Raalte DH; Herrema H; Nieuwdorp M
Physiol Rep; 2019 Aug; 7(16):e14199. PubMed ID: 31423751
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes.
van Raalte DH; Bjornstad P; Persson F; Powell DR; de Cassia Castro R; Wang PS; Liu M; Heerspink HJL; Cherney D
Diabetes Care; 2019 Oct; 42(10):1921-1929. PubMed ID: 31371432
[TBL] [Abstract][Full Text] [Related]
17. Assessment of real-time and quantitative changes in renal hemodynamics in healthy overweight males: Contrast-enhanced ultrasonography vs para-aminohippuric acid clearance.
Muskiet MHA; Emanuel AL; Smits MM; Tonneijck L; Meijer RI; Joles JA; Serné EH; van Raalte DH
Microcirculation; 2019 Oct; 26(7):e12580. PubMed ID: 31313410
[TBL] [Abstract][Full Text] [Related]
18. Effects of Light Therapy on Mood and Insulin Sensitivity in Patients With Type 2 Diabetes and Depression: Results From a Randomized Placebo-Controlled Trial.
Brouwer A; van Raalte DH; Nguyen HT; Rutters F; van de Ven PM; Elders PJM; Moll AC; Van Someren EJW; Snoek FJ; Beekman ATF; Bremmer MA
Diabetes Care; 2019 Apr; 42(4):529-538. PubMed ID: 30796110
[TBL] [Abstract][Full Text] [Related]
19. Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus.
Tonneijck L; Muskiet MHA; Blijdorp CJ; Smits MM; Twisk JW; Kramer MHH; Danser AHJ; Diamant M; Joles JA; Hoorn EJ; van Raalte DH
Am J Physiol Renal Physiol; 2019 Feb; 316(2):F231-F240. PubMed ID: 30353743
[TBL] [Abstract][Full Text] [Related]
20. Lixisenatide Versus Insulin Glulisine on Fasting and Postbreakfast Systemic Hemodynamics in Type 2 Diabetes Mellitus Patients.
Tonneijck L; Muskiet MHA; Twisk JW; Kramer MHH; Danser AHJ; Joles JA; Smits MM; van Raalte DH
Hypertension; 2018 Aug; 72(2):314-322. PubMed ID: 29915021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
